Corpus Intelligence IC Memo — SUNNYVIEW HOSPITAL AND REHABILITATIO 2026-04-26 13:36 UTC
IC Memo — SUNNYVIEW HOSPITAL AND REHABILITATIO
Investment Committee Memorandum | NY | 17 beds | Grade C | EBITDA uplift $4.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SUNNYVIEW HOSPITAL AND REHABILITATIO

CCN 330406 | SCHENECTADY, NY | 17 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SUNNYVIEW HOSPITAL AND REHABILITATIO is a 17-bed suburban community hospital in SCHENECTADY, NY with $56.6M in net patient revenue and a -9.4% operating margin. The hospital serves a payer mix of 47.9% Medicare, 0.7% Medicaid, and 51.4% commercial.

Thesis: Turnaround. Our ML models identify $4.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.4% to -2.1% (+736bps).

Net Revenue HCRIS$56.6M
Current EBITDA COMPUTED$-5.3M
Operating Margin COMPUTED-9.4%
Occupancy HCRIS64.8%
Revenue / Bed COMPUTED$3.3M
Net-to-Gross HCRIS44.2%
Distress Probability ML42.9%

2. Market Context & Competitive Position

196
NY Hospitals
-17.5%
State Median Margin
26
Comparable Hospitals

NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of -9.4% places it above the state median. Among 26 size-comparable peers (8-34 beds), the median margin is -17.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-34), prioritizing same-state peers. 26 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SUNNYVIEW HOSPITAL AND REHABIL (Target)NY17$56.6M-9.4%
NEW YORK EYE AND EAR INFIRMARYNY15$112.8M-28.0%
LEWIS COUNTY GENERAL HOSPITALNY25$70.3M-17.6%
CARTHAGE AREA HOSPITALNY25$59.4M-12.3%
COMMUNITY MEMORIAL HOSPITALNY25$53.2M-6.7%
MASSENA MEMORIAL HOSPITALNY25$48.4M-14.4%
ELIZABETHTOWN COMMUNITY HOSPITNY25$47.4M-7.8%
ST. JAMES HOSPITALNY15$46.3M-27.4%
LITTLE FALLS HOSPITALNY25$42.5M7.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$689K+122bp9mo
Clean Claim Rate88.0%96.0%$36K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$689K
Clean Claim Rate
$36K
Total EBITDA Uplift$4.2M
Current EBITDA$-5.3M
+ RCM Uplift+$4.2M
Pro Forma EBITDA$-1.2M
Current Margin-9.4%
Pro Forma Margin-2.1%
WC Released (1x)$2.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-8.2M$6.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-8.2M$4.4M0.00x-100.0%
Bull Case9.0x11.0x$-7.4M$15.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.4M$14.7M0.00x-100.0%
Bear Case11.0x10.0x$-9.0M$-11.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-9.0M$-15.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 26 hospitals with 8-34 beds
  • Same-state prioritization (n=27)
  • Comp margins: P25=-27.4% / P50=-17.6% / P75=-7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.